AAPL331.91-6.28 (-1.86%) ▼|ABBV257.84-5.46 (-2.07%) ▼|ABT105.47-2.54 (-2.35%) ▼|ACN162.03-11.14 (-6.43%) ▼|ADBE246.27-17.16 (-6.51%) ▼|AMAT496.83+60.38 (+13.83%) ▲|AMD485.63+56.07 (+13.05%) ▲|AMGN382.94-4.70 (-1.21%) ▼|AMT173.10-6.16 (-3.44%) ▼|AMZN238.70+12.05 (+5.32%) ▲|AVGO386.98+16.66 (+4.50%) ▲|AXP336.57+5.07 (+1.53%) ▲|BA220.11+6.10 (+2.85%) ▲|BAC61.60+0.53 (+0.86%) ▲|BKNG191.85-9.45 (-4.69%) ▼|BLK1,096.69+17.50 (+1.62%) ▲|BMY64.34+1.24 (+1.97%) ▲|BNY155.77+3.27 (+2.14%) ▲|BRK-B505.41-3.76 (-0.74%) ▼|C131.28+4.15 (+3.26%) ▲|CAT805.81+23.10 (+2.95%) ▲|CL91.38-2.12 (-2.26%) ▼|CMCSA23.48-1.13 (-4.59%) ▼|COF207.63-1.08 (-0.52%) ▼|COP117.48-0.58 (-0.49%) ▼|COST952.29-21.75 (-2.23%) ▼|CRM179.05-9.33 (-4.95%) ▼|CSCO113.47+0.99 (+0.88%) ▲|CVS105.00-0.92 (-0.87%) ▼|CVX190.82-1.05 (-0.54%) ▼|DE597.99-12.96 (-2.12%) ▼|DHR196.44-0.06 (-0.03%) ▼|DIS95.43-3.06 (-3.10%) ▼|DUK125.81-3.27 (-2.53%) ▼|EMR148.68+2.95 (+2.02%) ▲|FDX306.04-2.58 (-0.83%) ▼|GD379.41-1.55 (-0.41%) ▼|GE353.65+3.02 (+0.86%) ▲|GEV965.65+65.37 (+7.26%) ▲|GILD129.74-2.99 (-2.25%) ▼|GM87.14-2.26 (-2.53%) ▼|GOOG334.38-1.38 (-0.41%) ▼|GOOGL334.85-1.86 (-0.55%) ▼|GS1,018.89+38.14 (+3.89%) ▲|HD332.47-5.80 (-1.71%) ▼|HON239.40-1.72 (-0.71%) ▼|IBM222.37-4.08 (-1.80%) ▼|INTC92.49+10.61 (+12.96%) ▲|INTU309.85-23.29 (-6.99%) ▼|ISRG350.31-2.79 (-0.79%) ▼|JNJ256.36-9.18 (-3.46%) ▼|JPM350.32+5.61 (+1.63%) ▲|KO87.94-1.14 (-1.28%) ▼|LIN504.67-6.51 (-1.27%) ▼|LLY1,164.65-45.38 (-3.75%) ▼|LMT560.39-8.82 (-1.55%) ▼|LOW210.00-5.68 (-2.63%) ▼|LRCX296.56+44.21 (+17.52%) ▲|MA574.00+10.68 (+1.90%) ▲|MCD267.41-4.11 (-1.51%) ▼|MDLZ62.71-2.28 (-3.51%) ▼|MDT85.54-2.00 (-2.28%) ▼|META532.32-53.29 (-9.10%) ▼|MMM175.41-2.54 (-1.43%) ▼|MO67.94-6.98 (-9.32%) ▼|MRK129.14-1.22 (-0.94%) ▼|MS209.29+6.16 (+3.03%) ▲|MSFT455.28+64.74 (+16.58%) ▲|MU855.91+116.91 (+15.82%) ▲|NEE87.34-1.12 (-1.27%) ▼|NFLX72.53-1.11 (-1.50%) ▼|NKE41.89-1.34 (-3.09%) ▼|NOW108.44-7.32 (-6.32%) ▼|NVDA193.87+3.86 (+2.03%) ▲|ORCL125.69+7.95 (+6.75%) ▲|PEP139.94-3.56 (-2.48%) ▼|PFE24.73-0.42 (-1.67%) ▼|PG142.88-3.22 (-2.20%) ▼|PLTR121.67-1.34 (-1.09%) ▼|PM192.11-6.33 (-3.19%) ▼|QCOM153.38-2.30 (-1.48%) ▼|RTX211.66-3.60 (-1.67%) ▼|SBUX107.45+3.31 (+3.17%) ▲|SCHW104.34-0.13 (-0.12%) ▼|SO93.94-2.11 (-2.20%) ▼|SPG229.97-5.64 (-2.39%) ▼|T23.23-0.72 (-2.99%) ▼|TMO569.93-6.53 (-1.13%) ▼|TMUS175.30-6.22 (-3.43%) ▼|TSLA306.85+8.53 (+2.86%) ▲|TXN281.02+9.72 (+3.58%) ▲|UBER69.27-1.94 (-2.72%) ▼|UNH424.74+4.17 (+0.99%) ▲|UNP285.76-6.43 (-2.20%) ▼|UPS103.06-1.50 (-1.43%) ▼|USB62.95+0.13 (+0.21%) ▲|V364.45-4.28 (-1.16%) ▼|VZ46.04-1.19 (-2.51%) ▼|WFC84.95+1.08 (+1.29%) ▲|WMT110.93-3.29 (-2.88%) ▼|XOM156.08-0.67 (-0.43%) ▼|AAPL331.91-6.28 (-1.86%) ▼|ABBV257.84-5.46 (-2.07%) ▼|ABT105.47-2.54 (-2.35%) ▼|ACN162.03-11.14 (-6.43%) ▼|ADBE246.27-17.16 (-6.51%) ▼|AMAT496.83+60.38 (+13.83%) ▲|AMD485.63+56.07 (+13.05%) ▲|AMGN382.94-4.70 (-1.21%) ▼|AMT173.10-6.16 (-3.44%) ▼|AMZN238.70+12.05 (+5.32%) ▲|AVGO386.98+16.66 (+4.50%) ▲|AXP336.57+5.07 (+1.53%) ▲|BA220.11+6.10 (+2.85%) ▲|BAC61.60+0.53 (+0.86%) ▲|BKNG191.85-9.45 (-4.69%) ▼|BLK1,096.69+17.50 (+1.62%) ▲|BMY64.34+1.24 (+1.97%) ▲|BNY155.77+3.27 (+2.14%) ▲|BRK-B505.41-3.76 (-0.74%) ▼|C131.28+4.15 (+3.26%) ▲|CAT805.81+23.10 (+2.95%) ▲|CL91.38-2.12 (-2.26%) ▼|CMCSA23.48-1.13 (-4.59%) ▼|COF207.63-1.08 (-0.52%) ▼|COP117.48-0.58 (-0.49%) ▼|COST952.29-21.75 (-2.23%) ▼|CRM179.05-9.33 (-4.95%) ▼|CSCO113.47+0.99 (+0.88%) ▲|CVS105.00-0.92 (-0.87%) ▼|CVX190.82-1.05 (-0.54%) ▼|DE597.99-12.96 (-2.12%) ▼|DHR196.44-0.06 (-0.03%) ▼|DIS95.43-3.06 (-3.10%) ▼|DUK125.81-3.27 (-2.53%) ▼|EMR148.68+2.95 (+2.02%) ▲|FDX306.04-2.58 (-0.83%) ▼|GD379.41-1.55 (-0.41%) ▼|GE353.65+3.02 (+0.86%) ▲|GEV965.65+65.37 (+7.26%) ▲|GILD129.74-2.99 (-2.25%) ▼|GM87.14-2.26 (-2.53%) ▼|GOOG334.38-1.38 (-0.41%) ▼|GOOGL334.85-1.86 (-0.55%) ▼|GS1,018.89+38.14 (+3.89%) ▲|HD332.47-5.80 (-1.71%) ▼|HON239.40-1.72 (-0.71%) ▼|IBM222.37-4.08 (-1.80%) ▼|INTC92.49+10.61 (+12.96%) ▲|INTU309.85-23.29 (-6.99%) ▼|ISRG350.31-2.79 (-0.79%) ▼|JNJ256.36-9.18 (-3.46%) ▼|JPM350.32+5.61 (+1.63%) ▲|KO87.94-1.14 (-1.28%) ▼|LIN504.67-6.51 (-1.27%) ▼|LLY1,164.65-45.38 (-3.75%) ▼|LMT560.39-8.82 (-1.55%) ▼|LOW210.00-5.68 (-2.63%) ▼|LRCX296.56+44.21 (+17.52%) ▲|MA574.00+10.68 (+1.90%) ▲|MCD267.41-4.11 (-1.51%) ▼|MDLZ62.71-2.28 (-3.51%) ▼|MDT85.54-2.00 (-2.28%) ▼|META532.32-53.29 (-9.10%) ▼|MMM175.41-2.54 (-1.43%) ▼|MO67.94-6.98 (-9.32%) ▼|MRK129.14-1.22 (-0.94%) ▼|MS209.29+6.16 (+3.03%) ▲|MSFT455.28+64.74 (+16.58%) ▲|MU855.91+116.91 (+15.82%) ▲|NEE87.34-1.12 (-1.27%) ▼|NFLX72.53-1.11 (-1.50%) ▼|NKE41.89-1.34 (-3.09%) ▼|NOW108.44-7.32 (-6.32%) ▼|NVDA193.87+3.86 (+2.03%) ▲|ORCL125.69+7.95 (+6.75%) ▲|PEP139.94-3.56 (-2.48%) ▼|PFE24.73-0.42 (-1.67%) ▼|PG142.88-3.22 (-2.20%) ▼|PLTR121.67-1.34 (-1.09%) ▼|PM192.11-6.33 (-3.19%) ▼|QCOM153.38-2.30 (-1.48%) ▼|RTX211.66-3.60 (-1.67%) ▼|SBUX107.45+3.31 (+3.17%) ▲|SCHW104.34-0.13 (-0.12%) ▼|SO93.94-2.11 (-2.20%) ▼|SPG229.97-5.64 (-2.39%) ▼|T23.23-0.72 (-2.99%) ▼|TMO569.93-6.53 (-1.13%) ▼|TMUS175.30-6.22 (-3.43%) ▼|TSLA306.85+8.53 (+2.86%) ▲|TXN281.02+9.72 (+3.58%) ▲|UBER69.27-1.94 (-2.72%) ▼|UNH424.74+4.17 (+0.99%) ▲|UNP285.76-6.43 (-2.20%) ▼|UPS103.06-1.50 (-1.43%) ▼|USB62.95+0.13 (+0.21%) ▲|V364.45-4.28 (-1.16%) ▼|VZ46.04-1.19 (-2.51%) ▼|WFC84.95+1.08 (+1.29%) ▲|WMT110.93-3.29 (-2.88%) ▼|XOM156.08-0.67 (-0.43%) ▼|
21.6 C
New York
Thursday, July 30, 2026

Tag: revenues

newssourceFORcompanyinformationcontent1releasesmarket

PRICESMART ANNOUNCES FISCAL 2025 THIRD QUARTER OPERATING RESULTS AND CHILE AS A POTENTIAL NEW MARKET

NET MERCHANDISE SALES GREW 8.0%COMPARABLE NET MERCHANDISE SALES INCREASED 7.0%$1.14 EARNINGS PER DILUTED SHARE SAN DIEGO, July 10, 2025 /PRNewswire/ -- PriceSmart, Inc. ("PriceSmart" or the...

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy

SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the appointment of Marc. R Theoret, M.D. to assume the newly created position of Senior Vice President, Regulatory Strategy, where he will focus on clinical regulatory strategy for Iovance’s pipeline. Effective immediately, Dr. Theoret will report to Dr. Raj K. Puri, M.D., Ph.D., Chief Regulatory Officer.

PUDO Inc. reports FY 2026 first quarter end results

TORONTO, July 10, 2025 /CNW/ - PUDO Inc. ("PUDO" or the "Company") (CSE: PDO) (OTCQB: PDPTF), today filed interim financial results (unaudited) and operational...

Con Edison to Report 2nd Quarter 2025 Earnings on August 7

NEW YORK, July 10, 2025 /PRNewswire/ -- Consolidated Edison, Inc. (Con Edison) (NYSE:ED) plans to report its 2nd Quarter 2025 earnings on August 7,...

FHLBank San Francisco Awards $5.1 Million in Grants for Affordable Housing in Nevada

FHLBank San Francisco Awards $5.1 Million in Grants for Affordable Housing in Nevada

CSA announces final amendments to Multilateral Instrument 13-102 System Fees

TORONTO, July 10, 2025 /CNW/ - The Canadian Securities Administrators (CSA) today published in final form amendments to Multilateral Instrument 13-102 System Fees (MI...

Genpact Recognized as One of America’s Best Midsize Companies by TIME

Climbs to #100 in the 2025 top 500 list, demonstrating Genpact's commitment to innovation, people-first culture, and client impact  NEW YORK, July 10, 2025  /PRNewswire/...

Diagnostics Transformed: $37 Billion Immunoassay Market Evolves with AI, Miniaturization, and POC Growth, reports Kalorama Information

ARLINGTON, Va., July 10, 2025 /PRNewswire/ -- Kalorama Information, a leading healthcare market intelligence firm, has published a comprehensive new report, Global Immunoassay Market:...

NextNRG Reports Preliminary June 2025 Revenue Growth of 231% Year-Over-Year

NextNRG Reports Preliminary June 2025 Revenue Growth of 231% Year-Over-Year

SolarBank Issues Update on Strategic Positioning Amid Shifting U.S. and Canadian Policy Landscape

TORONTO, July 10, 2025 /CNW/ - SolarBank Corporation (Cboe CA: SUNN) (NASDAQ: SUUN) ("SolarBank" or the "Company"), a leading North American developer, owner, and operator of...

AleAnna, Inc. Announces Strong Early Production and Revenue Results at Longanesi Field

Targeted Maximum 2025 Production Rate Has Been Achieved After Less Than 6 Weeks of Production 
Targeted Maximum 2025 Production Rate Has Been Achieved After Less Than 6 Weeks of Production

Main Street Announces Second Quarter 2025 Private Loan Portfolio Activity

HOUSTON, July 10, 2025 /PRNewswire/ -- Main Street Capital Corporation (NYSE: MAIN) ("Main Street") is pleased to announce the following recent activity in its...

Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform

 - Regina Hodits, Managing Director to join NUCLIDIUM’s Board of Directors

[Latest] Global Pet Oral Care Products Market Size/Share Worth USD 3,583.11 Million by 2034 at a 5.73% CAGR: Custom Market Insights (Analysis, Outlook, Leaders,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Pet Oral Care Products Market size & share revenue was valued at approximately USD 2,056.87 Million in 2024 and is expected to reach USD 2,169.79 Million in 2025 and is expected to reach around USD 3,583.11 Million by 2034, at a CAGR of 5.73% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are All4pets, AllAccem Inc., Central Garden & Pet Company, Ceva, Ceva Santé Animale, Cosmos Corporation, Dechra Pharmaceuticals plc, Goran Pharma Pvt. Ltd., Hill’s Pet Nutrition Inc., Imrex Inc., Kane Biotech, Inc., Mars Incorporated, Nestlé Purina PetCare Company (Nestlé S.A.), Petzlife UK, Vetoquinol SA, Virbac and others. 
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Pet Oral Care Products Market size & share revenue was valued at approximately USD 2,056.87 Million in 2024 and is expected to reach USD 2,169.79 Million in 2025 and is expected to reach around USD 3,583.11 Million by 2034, at a CAGR of 5.73% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are All4pets, AllAccem Inc., Central Garden & Pet Company, Ceva, Ceva Santé Animale, Cosmos Corporation, Dechra Pharmaceuticals plc, Goran Pharma Pvt. Ltd., Hill’s Pet Nutrition Inc., Imrex Inc., Kane Biotech, Inc., Mars Incorporated, Nestlé Purina PetCare Company (Nestlé S.A.), Petzlife UK, Vetoquinol SA, Virbac and others.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRevenues

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers